scholarly journals Management of Bronchiolitis in Community Hospitals in Ontario: a Multicentre Cohort Study

CJEM ◽  
2016 ◽  
Vol 18 (6) ◽  
pp. 443-452 ◽  
Author(s):  
Amy C. Plint ◽  
Monica Taljaard ◽  
Candice McGahern ◽  
Shannon D. Scott ◽  
Jeremy M. Grimshaw ◽  
...  
Keyword(s):  
Hospital Admission ◽  
First Episode ◽  
Upper Respiratory Tract ◽  
Community Hospitals ◽  
Translation Strategies ◽  
Admission Rates ◽  
Knowledge Translation Strategies ◽  
Respiratory Syncytial Virus Season ◽  
Chest X Ray ◽  
Syncytial Virus

AbstractObjectivesBronchiolitis is the leading cause of hospital admission for infants, but few studies have examined management of this condition in community hospital settings. We reviewed the management of children with bronchiolitis presenting to community hospitals in Ontario.MethodsWe retrospectively reviewed a consecutive cohort of infants less than 12 months old with bronchiolitis who presented to 28 Ontario community hospitals over a two-year period. Bronchiolitis was defined as first episode of wheezing associated with signs of an upper respiratory tract infection during respiratory syncytial virus season.ResultsOf 543 eligible children, 161 (29.7%, 95% Confidence Interval (CI) 22.3 to 37.0%) were admitted to hospital. Hospital admission rates varied widely (Interquartile Range 0%-40.3%). Bronchodilator use was widespread in the emergency department (ED) (79.7% of patients, 95% CI 75.0 to 84.5%) and on the inpatient wards (94.4% of patients, 95% CI 90.2 to 98.6%). Salbutamol was the most commonly used bronchodilator. At ED discharge 44.7% (95% CI 37.5 to 51.9%) of patients were prescribed a bronchodilator medication. Approximately one-third of ED patients (30.8%, 95% CI 22.7 to 38.8%), 50.3% (95% CI 37.7 to 63.0%) of inpatients, and 23.5% (95% CI 14.4 to 32.7) of patients discharged from the ED were treated with corticosteroids. The most common investigation obtained was a chest x-ray (60.2% of all children; 95% CI 51.9 to 68.5%).ConclusionsInfants with bronchiolitis receive medications and investigations for which there is little evidence of benefit. This suggests a need for knowledge translation strategies directed to community hospitals.

scholarly journals Variation in hospital admission in febrile children evaluated at the Emergency Department (ED) in Europe: PERFORM, a multicentre prospective observational study

PLoS ONE ◽  
2021 ◽  
Vol 16 (1) ◽  
pp. e0244810
Author(s):  
Dorine M. Borensztajn ◽  
Nienke N. Hagedoorn ◽  
Irene Rivero Calle ◽  
Ian K. Maconochie ◽  
Ulrich von Both ◽  
...  
Keyword(s):  
Emergency Department ◽  
Hospital Admission ◽  
Disease Severity ◽  
Severe Disease ◽  
Patient Characteristics ◽  
Care Utilization ◽  
Upper Respiratory Tract ◽  
Admission Rates ◽  
Patient Groups ◽  
Tract Infections

Objectives Hospitalisation is frequently used as a marker of disease severity in observational Emergency Department (ED) studies. The comparison of ED admission rates is complex in potentially being influenced by the characteristics of the region, ED, physician and patient. We aimed to study variation in ED admission rates of febrile children, to assess whether variation could be explained by disease severity and to identify patient groups with large variation, in order to use this to reduce unnecessary health care utilization that is often due to practice variation. Design MOFICHE (Management and Outcome of Fever in children in Europe, part of the PERFORM study, www.perform2020.org), is a prospective cohort study using routinely collected data on febrile children regarding patient characteristics (age, referral, vital signs and clinical alarming signs), diagnostic tests, therapy, diagnosis and hospital admission. Setting and participants Data were collected on febrile children aged 0–18 years presenting to 12 European EDs (2017–2018). Main outcome measures We compared admission rates between EDs by using standardised admission rates after adjusting for patient characteristics and initiated tests at the ED, where standardised rates >1 demonstrate higher admission rates than expected and rates <1 indicate lower rates than expected based on the ED patient population. Results We included 38,120 children. Of those, 9.695 (25.4%) were admitted to a general ward (range EDs 5.1–54.5%). Adjusted standardised admission rates ranged between 0.6 and 1.5. The largest variation was seen in short admission rates (0.1–5.0), PICU admission rates (0.2–2.2), upper respiratory tract infections (0.4–1.7) and fever without focus (0.5–2.7). Variation was small in sepsis/meningitis (0.9–1.1). Conclusions Large variation exists in admission rates of febrile children evaluated at European EDs, however, this variation is largely reduced after correcting for patient characteristics and therefore overall admission rates seem to adequately reflect disease severity or a potential for a severe disease course. However, for certain patient groups variation remains high even after adjusting for patient characteristics.

Furosemide in end-stage heart failure: community subcutaneous infusions

2020 ◽  
pp. bmjspcare-2019-002158
Author(s):  
Andrew Brown ◽  
Katharine Westley ◽  
Judith Robson ◽  
Leonie Armstrong ◽  
Iain Matthews ◽  
...  
Keyword(s):  
Heart Failure ◽  
Weight Loss ◽  
Hospital Admission ◽  
Initial Treatment ◽  
Hospital Admissions ◽  
Patient Choice ◽  
First Episode ◽  
Admission Rates ◽  
End Stage Heart Failure ◽  
End Stage

BackgroundIn chronic heart failure many patients have recurrent hospital admissions and it is the leading cause of admission in people aged over 65 years. In those with end-stage heart failure, there is limited evidence that furosemide can be given subcutaneously to relieve symptoms and avoid hospital admission.MethodWe initiated a community-based continuous subcutaneous infusion (CSCI) furosemide service for the treatment of advanced heart failure. We aimed to increase patient choice, offer an alternative to hospital admission and, in patients at the end of their life, allow them to die at their preferred place of care with symptom alleviation. We retrospectively reviewed case notes.Results36 consecutive episodes of CSCI of treatment were recorded in 28 patients. 15 patients (54%) survived beyond the initial treatment course with 13 patients (87%) avoiding acute hospital admission. There was a reduction in mean hospital admission rates from 2.87 to 0.73 (p<0.001) in the 6-month periods either side of the first episode of CSCI furosemide. A median reduction of 4 kg weight loss was recorded. 13 patients died during the initial treatment course. 12 (92%) died at home and 1 died at the hospital palliative care unit. All had symptoms controlled.ConclusionSubcutaneous furosemide can be successfully delivered in the community. In addition to palliation in the final days of life, community subcutaneous furosemide can be an effective treatment leading to weight loss and improved symptoms with survival for several months.

EFFICACY OF ALBUTEROL IN THE MANAGEMENT OF BRONCHIOLITIS

PEDIATRICS ◽  
1995 ◽  
Vol 96 (2) ◽  
pp. 397-398
Author(s):  
Napoleon Lee ◽  
Brett Kettelhut ◽  
Roger H. Kobayashi
Keyword(s):  
Heart Rate ◽  
Previous Treatment ◽  
Controlled Study ◽  
First Episode ◽  
Double Blind ◽  
Treatment Groups ◽  
Admission Rates ◽  
History Of ◽  
Group 2 ◽  
Syncytial Virus

Purpose of the Study. To determine the efficacy and safety of albuterol (0.15 mg/kg per dose) in the management of bronchiolitis. Study Population. Eighty-eight infants (mean age, 5.5 months old) with their first episode of wheezing due to bronchiolitis were enrolled. Exclusionary criteria included previous treatment with bronchodilators, mechanical ventilation, or a history of cardiorespiratory diseases. Methods. This was a double-blind, placebo-controlled study with infants randomly assigned into four treatment groups: 1) those who received nebulized albuterol (0.15 mg/kg) 2) those who received oral albuterol, 3) those who received nebulized placebo, and 4) those who received oral placebo. Patients were assessed at baseline, 30 minutes, and 60 minutes after treatment for respiratory rate (RR), symptom score (SC), heart rate (HR), and pulse oximeter (SPO2). Seventy-five had nasopharyngeal aspirate cultures perfomed. Results. Thirty-six (48%) of nasopharyngeal aspirates were positive for respiratory syncytial virus (RSV) and were equally distributed among the four groups. Four others had cultures positive for other viruses. HR, RR, SC, and SPO2 did not differ after 30 minutes and 60 minutes from initial treatment for groups 1, 3, and 4. Results were similar for group 2 except for an increase in heart rate (+15 beats/min) at 60 minutes (P = .006). Hospital admission rates were similar for all four groups. Reviewer's Comments. Albuterol in either form did not alter the course of bronchiolitis in infants. Care in selection of study infants was taken to identify those infants with wheezing due to a viral bronchiolitis and exclude other causes of wheezing.

scholarly journals Influence of seasonal variation on severity and outcomes in acute bronchiolitis

2017 ◽  
Vol 4 (6) ◽  
pp. 2032
Author(s):  
Shaik Ateal Saheb ◽  
R. Samba Siva Reddy
Keyword(s):  
Significant Trend ◽  
Seasonal Effects ◽  
First Episode ◽  
First Year ◽  
Acute Bronchiolitis ◽  
Infant Deaths ◽  
Indian Context ◽  
Chest X Ray ◽  
Context Data ◽  
Syncytial Virus

Background: Bronchiolitis is a predominant cause of respiratory insufficiency and hospitalization in infants during the first year of their life. Respiratory syncytial virus (RSV) has been the major causative virus; other viruses also cause bronchiolitis. Some are activated in winter while another virus in non-winter seasons. This seasonal trend affects the morbidity in infants. In the Indian context, data regarding seasonal influence on the severity and complications of acute bronchiolitis is less. Hence, this study was undertaken to assess the influence of season on morbidity on mortality in acute bronchiolitis.Methods: Infants or children <2 years of age, with the first episode of acute bronchiolitis diagnosed clinically, were evaluated. Clinical, demographic, radiological and risk factors were recorded and correlated with seasons.Results: The age of the infants was 4.0±2.9 months. Peak occurrence (87.7%) was within six months of age. 78/105 (74.3%) of bronchiolitis occurred during July to December. 22/105 (20.9%) were mild, 43/105 (43.9%) were moderate, and 40/105 (38.9%) were severe. The order of chest X-ray findings are consolidation <atelectasis <normal <pulmonary infiltrates <bilateral Hyperareation. Apnea was seen in 2.9%, Otitis media in 7.6% and seizures in 3.8% of infants. The season did not show statistically significant trend on the severity of bronchiolitis. There were no infant deaths due to bronchiolitis in the present study.Conclusions: In the present study, the season did not show statistically significant trend on the severity of bronchiolitis. Studies with more extensive population are needed to reassess the seasonal effects on morbidity of acute bronchiolitis.

scholarly journals Prevalence of BRD-Related Viral Pathogens in the Upper Respiratory Tract of Swiss Veal Calves

Animals ◽  
2021 ◽  
Vol 11 (7) ◽  
pp. 1940
Author(s):  
Eveline Studer ◽  
Lutz Schönecker ◽  
Mireille Meylan ◽  
Dimitri Stucki ◽  
Ronald Dijkman ◽  
...  
Keyword(s):  
Risk Factors ◽  
Welfare Economic ◽  
Economic Losses ◽  
Nasopharyngeal Swab ◽  
Upper Respiratory Tract ◽  
Convenience Sample ◽  
Veal Calves ◽  
Mixed Regression ◽  
Influenza C Virus ◽  
Syncytial Virus

The prevention of bovine respiratory disease is important, as it may lead to impaired welfare, economic losses, and considerable antimicrobial use, which can be associated with antimicrobial resistance. The aim of this study was to describe the prevalence of respiratory viruses and to identify risk factors for their occurrence. A convenience sample of 764 deep nasopharyngeal swab samples from veal calves was screened by PCR for bovine respiratory syncytial virus (BRSV), bovine parainfluenza-3 virus (BPI3V), bovine coronavirus (BCoV), influenza D virus (IDV), and influenza C virus (ICV). The following prevalence rates were observed: BRSV, 2.1%; BPI3V, 3.3%; BCoV, 53.5%; IDV, 4.1%; ICV, 0%. Logistic mixed regression models were built for BCoV to explore associations with calf management and housing. Positive swab samples were more frequent in younger calves than older calves (>100 days; p < 0.001). The probability of detecting BCoV increased with increasing group size in young calves. Findings from this study suggested that young calves should be fattened in small groups to limit the risk of occurrence of BCoV, although an extended spectrum of risk factors for viral associated respiratory disorders such as nutritional aspects should be considered in future studies.

scholarly journals Theory-based approach to developing an implementation plan to support the adoption of a patient decision aid for Down syndrome prenatal screening

2021 ◽  
Vol 16 (1) ◽  
Author(s):  
Titilayo Tatiana Agbadjé ◽  
Matthew Menear ◽  
Marie-Pierre Gagnon ◽  
France Légaré
Keyword(s):  
Prenatal Care ◽  
Knowledge Translation ◽  
Pregnant Women ◽  
Decision Aid ◽  
Prenatal Screening ◽  
Clinical Implementation ◽  
Implementation Plan ◽  
Translation Strategies ◽  
Knowledge To Action ◽  
Knowledge Translation Strategies

Abstract Background Our team has developed a decision aid to help pregnant women and their partners make informed decisions about Down syndrome prenatal screening. However, the decision aid is not yet widely available in Quebec’s prenatal care pathways. Objective We sought to identify knowledge translation strategies and develop an implementation plan to promote the use of the decision aid in prenatal care services in Quebec, Canada. Methods Guided by the Knowledge-to-Action Framework and the Theoretical Domains Framework, we performed a synthesis of our research (11 publications) on prenatal screening in Quebec and on the decision aid. Two authors independently reviewed the 11 articles, extracted information, and mapped it onto the Knowledge-to-Action framework. Using participatory action research methods, we then recruited pregnant women, health professionals, managers of three prenatal care services, and researchers to (a) identify the different clinical pathways followed by pregnant women and (b) select knowledge translation strategies for a clinical implementation plan. Then, based on all the information gathered, the authors established a consensus on strategies to include in the plan. Results Our knowledge synthesis showed that pregnant women and their partners are not sufficiently involved in the decision-making process about prenatal screening and that there are numerous barriers and facilitators of the use of the decision aid in clinical practice (e.g., low intention to use it among health providers). Using a participatory action approach, we met with five pregnant women, three managers, and six health professionals. They informed us about three of Quebec’s prenatal care pathways and helped us identify 20 knowledge translation strategies (e.g., nurse discusses decision aid with women before they meet the doctor) to include in a clinical implementation plan. The research team reached a consensus about the clinical plan and also about broader organizational strategies, such as training healthcare providers in the use of the decision aid, monitoring its impact (e.g., measure decisional conflict) and sustaining its use (e.g., engage key stakeholders in the implementation process). Conclusion Next steps are to pilot our implementation plan while further identifying global strategies that target institutional, policy, and systemic supports for implementation.

scholarly journals 1683. Hospital Admission Patterns in Adult Patients with Complicated Urinary Tract Infections (cUTIs): Identification of Potentially Avoidable Hospital Admissions Across United States (US) Hospitals

2020 ◽  
Vol 7 (Supplement_1) ◽  
pp. S825-S826
Author(s):  
Thomas Lodise ◽  
Teena Chopra ◽  
Brian Nathanson ◽  
Katherine Sulham
Keyword(s):  
Hospital Admission ◽  
Hospital Admissions ◽  
Panel Member ◽  
Inclusion Criteria ◽  
Independent Contractor ◽  
Healthcare Database ◽  
Admission Rates ◽  
Comorbidity Index ◽  
Multi Center Study ◽  
Tract Infections

Abstract Background There is an increase in hospital admissions for cUTI in the US despite apparent reductions in the severity of admissions. However, there are scant data on cUTI hospital admission rates from the emergency department (ED) stratified by age, infection severity, and presence of comorbidities. This study described US hospitalization patterns among adults who present to the ED with a cUTI. We sought to quantify the proportion of admissions that were potentially avoidable based on presence of sepsis and associated symtpoms as well as Charlston Comorbidity Index (CCI) scores. Methods A retrospective multi-center study using data from the Premier Healthcare Database (2013-18) was performed. Inclusion criteria: (1) age ≥ 18 years, (2) primary cUTI ED/inpatient discharge diagnosis, (3) positive blood or urine culture between index ED service days -5 to +2. Transfers from acute care facilities were excluded. Based on ICD-9/10 diagnosis codes present on admission, incidence of hospital admissions were stratified by age (≥ 65 years vs. &lt; 65 years), presence of sepsis (S), sepsis symptoms but no sepsis codes (SS) (e.g., fever, tachycardia, tachypnea, leukocytosis, etc.), and CCI. Results 187,789 patients met inclusion criteria. The mean (SD) age was 59.7 (21.9), 40.4% were male, 29.4% had sepsis, 16.7% had at least 1 SS symptom (but no S), and 53.9% had no evidence of S or SS. The median [IQR] CCI was 1 [0, 3]. 119,668 out of 187,789 (63.7%) were admitted to hospital. Among inpatients, median [IQR] length of stay (LOS) and total costs were 5 [3, 7] days and $7,956 [$4,834, $13,960] USD. Incidence of hospital admissions by age, presence of S/SS, and CCI score are shown in the Table. 18.9% of admissions (22,644/119,668) occurred in patients with no S/SS and a CCI ≤ 2. Their median [IQR] LOS and total costs were 3 [2, 5] days and $5,575 [$3,607, $9,133]. Incidence of Hospital Admission by Age, Charlson comorbidity index (CCI), Presence of Sepsis (S), and Presence of Sepsis Symptoms (SS) Conclusion Nearly 1 in 5 cUTI hospital admissions may be avoidable. Given the resources associated with the management of inpatients with cUTIs, these findings highlight the critical need for healthcare systems to develop well-defined criteria for hospital admission based on presence of comorbid conditions and infection severity. Preventing avoidable hospital admissions has the potential to save the healthcare system substantial costs. Disclosures Thomas Lodise, PharmD, PhD, Paratek Pharmaceuticals, Inc. (Consultant) Teena Chopra, MD, MPH, Spero Therapeutics (Consultant, Advisor or Review Panel member) Brian Nathanson, PhD, Spero Therapeutics (Independent Contractor) Katherine Sulham, MPH, Spero Therapeutics (Independent Contractor)

scholarly journals Challenges of using asthma admission rates as a measure of primary care quality in children: An international comparison

2021 ◽  
pp. 135581962110127
Author(s):  
Irina Lut ◽  
Kate Lewis ◽  
Linda Wijlaars ◽  
Ruth Gilbert ◽  
Tiffany Fitzpatrick ◽  
...  
Keyword(s):  
Primary Care ◽  
Hospital Admission ◽  
Hospital Admissions ◽  
Underlying Disease ◽  
Primary Diagnosis ◽  
Care Quality ◽  
Attendance Rates ◽  
Admission Rates ◽  
Primary Care Quality ◽  
Hospital Administrative

Objectives To demonstrate the challenges of interpreting cross-country comparisons of paediatric asthma hospital admission rates as an indicator of primary care quality. Methods We used hospital administrative data from >10 million children aged 6–15 years, resident in Austria, England, Finland, Iceland, Ontario (Canada), Sweden or Victoria (Australia) between 2008 and 2015. Asthma hospital admission and emergency department (ED) attendance rates were compared between countries using Poisson regression models, adjusted for age and sex. Results Hospital admission rates for asthma per 1000 child-years varied eight-fold across jurisdictions. Admission rates were 3.5 times higher when admissions with asthma recorded as any diagnosis were considered, compared with admissions with asthma as the primary diagnosis. Iceland had the lowest asthma admission rates; however, when ED attendance rates were considered, Sweden had the lowest rate of asthma hospital contacts. Conclusions The large variations in childhood hospital admission rates for asthma based on the whole child population reflect differing definitions, admission thresholds and underlying disease prevalence rather than primary care quality. Asthma hospital admissions among children diagnosed with asthma is a more meaningful indicator for inter-country comparisons of primary care quality.

scholarly journals MyCare study: protocol for a controlled trial evaluating the effect of a community-based intervention on psychosocial, clinical outcomes and hospital admission rates for adults with severe mental illness

BMJ Open ◽  
2020 ◽  
Vol 10 (11) ◽  
pp. e040610
Author(s):  
Renée O'Donnell ◽  
Melissa Savaglio ◽  
Debra Fast ◽  
Ash Vincent ◽  
Dave Vicary ◽  
...  
Keyword(s):  
Mental Health ◽  
Mental Illness ◽  
Hospital Admission ◽  
Clinical Outcomes ◽  
Controlled Trial ◽  
Community Based ◽  
Admission Rates ◽  
Mental Health Support ◽  
Health Support

IntroductionPeople with serious mental illness (SMI) often fail to receive adequate treatment. To provide a higher level of support, mental health systems have been reformed substantially to integrate mental healthcare into the community. MyCare is one such community-based mental health model of care. This paper describes the study protocol of a controlled trial examining the effect of MyCare on psychosocial and clinical outcomes and hospital admission and duration rates for adults with SMI.Methods and analysisThis is a multisite non-randomised controlled trial with a 3, 6 and 12-month follow-up period. The study participants will be adults (18–64 years of age) with SMI recruited from Hobart, Launceston and the North-West of Tasmania. The treatment group will include adults who receive both the MyCare intervention and standard mental health support; the control group will include adults who receive only standard mental health support. The primary outcome includes psychosocial and clinical functioning and the secondary outcome will examine hospital admission rates and duration of stay. Mixed-effects models will be used to examine outcome improvements between intake and follow-up. This trial will generate the evidence needed to evaluate the effect of a community mental health support programme delivered in Tasmania, Australia. If MyCare results in sustained positive outcomes for adults with SMI, it could potentially be scaled up more broadly across Australia, addressing the inequity and lack of comprehensive treatment that many individuals with SMI experience.Ethics and disseminationThis study has been approved by the Tasmanian Health and Medical Human Research Ethics Committee. The findings will be disseminated to participants and staff who delivered the intervention, submitted for publication in a peer-reviewed journal and shared at academic conferences.Trial registration numberACTRN12620000673943.

Sign in / Sign up

Export Citation Format

Share Document